Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer

Clinical trial NCT05435053 · TERMINATED

Trial details

NCT number: NCT05435053
Sponsor: Ismail Gögenur
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Cancer

Start date: 2022-09-08
Primary completion: 2023-08-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.